Manufacturing switch, DNA contamination, spike persistence, IgG4 immune tolerance, amyloid microclots, and regulatory failure converge on one conclusion: mRNA experiments must halt until safety is demonstrated.
The scientific case for pausing NIAID's intranasal whole-virus platforms: direct olfactory-nerve access to the brain, full structural proteins including spike, and the exact networks Dr. Annelise Bocquet mapped in 2025 now running U.S. policy.
Dr. Typhaine Pinsolle breaks down the Spike protein's engineered structure with HIV inserts, furin cleavage site, SV40 promoters, and why COVID mRNA injections don't meet the definition of a vaccine.
Molecular analysis of unusual 'calamari clots' reveals connections between lipid nanoparticles, PAD4 citrullination, and treatment-resistant thrombosis. Limited human evidence; proteomic data from investigator reports requires validation.
Kevin McCairn PhD's research on amyloid fibrin microclots causing Long COVID and post-vaccination syndromes. Evidence for nattokinase treatment and the crisis of misdiagnosis.
TL;DR The core finding: mRNA vaccines contain bacterial DNA with active SV40 promoter sequences—contamination confirmed by 9+ independent labs across four continents, with levels up to 627-fold above regulatory limits and 815-fold variance between batches....
When Pfizer switched from clinical trial production to mass manufacturing, they changed everything from DNA templates to purification methods. Internal emails reveal regulators were alarmed by unexpected DNA contaminants with known risks, while patent documents show manufacturers long understood these dangers.
Comprehensive investigation of SV40 DNA contamination in mRNA vaccines, featuring internal regulatory emails, the somatic hypermutation mechanism, manufacturer prior knowledge, and global independent lab confirmations.